Current status and prospective application of stem cell-based therapies for spinal cord injury

Current Stem Cell Research and Therapy

Volumn 6, Issue 2, 2011, Pages 93-104

  Das, Anjan Kumar ^a   Gopurappilly, Renjitha ^b   Parhar, Ishwar ^b  

^a Stempeutics Research Malaysia Sdn Bhd   (Malaysia)

^b MONASH UNIVERSITY MALAYSIA   (Malaysia)

Author keywords

Neural regeneration; Olfactory; Spinal cord injury; Stem cells; Transplantation

Indexed keywords

ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL LINEAGE; CELL TYPE; EMBRYONIC STEM CELL; FETAL STEM CELL; FIBROBLAST; HUMAN; IN VIVO STUDY; MESENCHYMAL STEM CELL TRANSPLANTATION; MULTIPLE SCLEROSIS; NEURAL STEM CELL; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; OLFACTORY ENSHEATHING CELL; PRIORITY JOURNAL; SPINAL CORD INJURY; SPINAL CORD REGENERATION; STEM CELL TRANSPLANTATION; STROMA CELL; TREATMENT OUTCOME; UMBILICAL CORD BLOOD;

ANIMALS; HUMANS; NERVE REGENERATION; SPINAL CORD INJURIES; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 79955686798     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488811795495477     Document Type: Article

References (125)

1. American Spinal Injury Association (www.asia-spinalinjury.org)
2. Eftekharpour E, Karimi-Abdolrezaee S. Current Status of experimental cell replacement approaches to spinal cord injury. Neurosurg Focus 2008; 24(3-4): E18.
3. Rowland JW, Hawryluk GWJ, Kwon B, Fehlings MG. Current status of acute spinal cord injury pathophysiology and emerging therapies: promise in the horizon. Neurosurg Focus 2008; 25[5]: E2.
4. Sekhon LH, Fehlings MG. Epidemiology, demographics and pathophysiology of acute spinal cord injury. Spine 2001; 26: S2- S12.
5. National Spinal Cord Injury Statistical Center Fact Sheet. National Spinal Cord Injury Center; Jun 2006.
6. Meyers A, Mitra M, Walker D, Wilber N, Allen D. Predictors of secondary conditions in a sample of independently living adults with high-level spinal cord injury. Top Spinal Cord Inj Rehabil 2000; 6(1): 1-7.
7. Schultz SS. Adult Stem cell Application in Spinal Cord Injury. Curr Drug Targets 2005; 6: 63-73.
8. Totoiu MO, Kierstead HS. Spinal Cord Injury is accompanied by chronic progressive demyelination. J Comp Neurol 2005; 486: 373- 383.
9. Bapiste DC, Fehlings MG. Pharmacological approaches to repair the injured Spinal cord. J Neurotrauma 2006; 23: 318-334.
10. Velardo MJ, Burger C, Williams PR, et al. Patterns of gene expression reveal a temporally orchestrated wound healing response in the injured spinal cord. J Neurosci 2004; 23: 8562-76.
11. Schwab NE. Nogo and axon regeneration. Curr Opin Nerobiol 2004; 1118-24.
12. Schwab ME. Repairing the Injured Spinal Cord. Science 2002;295: 1029-31.
13. Liu BP, Fournier A, GrandPre T, Strittmatter SM. Myelin-associated Glycoprotein as a functional ligand for the Nogo-66receptor.Science 2002; 297: 1190-93.
14. Willierth SM, Sakiyama-Elbert. Cell Therapy for Spinal CordRegeneration. Adv Drug Deliv Rev 2008; 60(2): 263-76.
15. Brustle O, Jones KN, Learish RD, Karram K, Chaudhary K, Wiestler OD. Embryonic stem cell-derived glial precursors: a sourceof myelinating transplants. Science 1999; 285: 754-56.
16. Jendelova P, Herynek V, Urdzikova L, et al. Magnetic ResonanceTracking of transplanted bone marrow and embryonic stem cellslabeled by iron oxide nanaoparticles in rat brain and spinal cord. J Neurosci Res 2004; 76: 232-43.
17. Howard MJ, Liu S, Schottler F, Joy Snider B, Jacquin MF. Transplantation of apoptosis resistant embryonic stem cells into injured rat spinal cord. Somatosens Mot Res 2005; 22: 37-44.
18. Nistor GI, Totoiu MO, Haque N, Carpenter MK, Keirstead HS.Human Embryonic Stem cells differentiate into ologodendrocytesin high purity and myelinate after spinal cord transplantation. Glia2005; 49: 385-396.
19. Kierstead HS, Nistor G, Bernal G, et al. Human Embryonic stemcell derived oligodendrocyte progenitor cell transplants remyelinateand restore locomotion after spinal cord injury. J Nerosci 2005; 25:4694-705.
20. Hatami M, Mehrjardi NZ, Kiani S, et al. Human embryonic stemcell-derived neural precursor transplants in collagen scaffolds promoterecovery in injured rat spinal cord. Cytotherapy 2009; 22: 1-13.
21. Faulkner J, Keirstead HS. Human embryonic stem cell-derivedoligodendrocyte progenitors for the treatment of spinal cord injury.Transpl Immunol 2005; 15: 131-42.
22. Cloutier F, Siegenthaler MM, Nistor G, Keirstead HS. Transplantation of human embryonic stem cell-derived oligodendrocyte progenitorsinto rat spinal cord injuries does not cause harm. Regen Med 2006; 1: 469-79.
23. Drucker- Colin R, Verdugo-Diaz L. Cell Transplantation for Parkinson's disease: Present Status. Cell Mol Neurorobiol 2004; 24:310-16.
24. Nakamura M, Okano H, Toyama Y, Dai HN, Finn TP, Bregman BS. Transplantation of embryonic spinal cord-derived neurospheres support growth of supraspinal projections and functional recovery after spinal cord injury in the neonatal rat. J Neurosci Res 2005;81(4): 457-68.
25. Mitsui T, Shumsky JS, Lepore AC, Murray M, Fischer I. Transplantation of neuronal and glial restricted precursors into contused spinal cord improves bladder and motor functions, decreases thermal hypersensitivity, and modifies intraspinal circuitry.J Neurosci2005; 25(42): 9624-9636.
26. Rao MS, Mattison MP. Stem Cell and Aging: Expanding the Possibilities.Mech Ageing Dev 2004; 122: 713-34.
27. Reynolds BA, Weiss S. Generation of Neurons and Astrocytes from isolated cells of the adult mammalian central nervous system. Science 1992; 255(5052): 1707-10.
28. Gage FH. Mammalian Neural Stem Cells. Science 2000; 287:1433-39.
29. Cao QL, Zhang YP, Howard RM, Walters WM, Tsoulfas P, WhittemoreSR. Differentiation of engrafted neuronal-restricted precursor cells is inhibited in the traumatically injured spinal cord. Exp Neurol 2002; 177: 349-59.
30. Enzmann GU, Benton RL, Woock JP, Howard RM. Tsouflas P,Whittemore SR. Consequences of noggin expression by neuralstem, glial, and neuronal precursor cells engrafted into the injured spinal cord. Exp Neurol 2005; 195: 293-04.
31. Teng YD, Lavik EB, Qu X, et al. Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells. Proc Natl Acad Sci USA 2002; 99:3024-29.
32. Ishii K, Nakamura M, Dai H, et al. Neutralization of ciliary nerotrphic factors reduces strocyte production from transplanted neural stem cells and promotes regeneration of corticospinal tract fibres in spinal cord injury. J Neurosci Res 2006; 84: 1669-81.
33. Cummings BJ, Uchida N, Tamaki SJ, et al. Human neural stemcells differentiate and promote locomotor recovery in spinal cord injured mice. Proc Natl Acad Sci USA 2005; 102: 1469-74.
34. Cummings BJ, Uchida N, Tamaki SJ, Anderson AJ. Human neuralcell differentiation following transplantation into spinal cord injuredmice: association of recovery of locomotor function. NeurolRes 2006; 28: 474-81.
35. Wu P, Tarasenko YI, Gu Y, Huang LY, Coggeshall RE, Yu Y.Region specific generation of cholinergic neurons from fetal humanneural stem cells grafted in adult rat. Nat Neurosci 2002; 5: 1271-78.
36. Fehlings MG, Tator CH. The relationships among the severity of spinal cord injury, residual neurological function, axon counts and counts of retrogradely labeled neurons after experimental spinalcord injury. Exp Neurol 1995; 132: 220-28.
37. Watanabe K, Nakamura M, Iwanami A, et al. Comparison between fetal spinal-cord- and forebrain-derived neural stem/progenitor cells as a source of transplantation for spinal cord injury. Dev Neurosci2004; 26: 275-287.
38. Karimi-Abdolrezaee S, Eftekharpour E, Wang J, Morshead CM, Fehlings MG. Delayed transplantation of adult neural precursor cells promotes remyelination and functional neurological recovery after spinal cord injury. J Neurosci 2006; 26(13): 3377-89.
39. Davies JE, Huang C, Proschel C, Noble M, Mayer-Proschel M, Davies SJ. Astrocytes derived from glial-restricted precursors promote spinal cord repair. J Biol 2006; 5(3): 7.
40. Biernaskie J, Sparling JS, Liu J, et al. Skin-derived precursorsgenerate myelinating Schwann cells that promote remyelinationand functional recovery after contusion spinal cord injury. J Neurosci2007; 27(36): 9545-9559.
41. Deng W, Obrocka M, Fischer I, Prockop DJ. In vitro differentiationof human marrow stromal cells into early progenitors of neuralcells by conditions that increase intracellular cyclic AMP. BiochemBiophys Res Commun 2001; 282: 148-52.
42. Woodbury D, Schwartz EJ. Prockop DJ, Black IB. Adult rat andhuman bone marrow stromal cells differentiate into neurons. J NeurosciRes 2000; 61: 364-70.
43. Sanchez-Ramos J, Song S, Cardozo-Pelaez F, et al. Adult bonemarrow stromal cells can differentiate into neural cells in vitro. ExpNeurol 2000; 164: 247-56.
44. Lu P, Lones LL, Tuszynski MH. BDNF- expressing marrow stromal cells support extensive axonal growth at sites of spinal cord injury. Exp Neurol 2005; 191: 344-60.
45. Jasper JG, Sankaranarayan S, Baskar S, et al. Autologous stem celltherapy in spinal cord injury: our initial experience. Journal ofStem Cells and Regenerative Medicine. http://www.pubstemcell.-com/monthly/004010700007.htm
46. Pal R, Venkataramana NK, Bansal A, Balaraju S, et al. Ex vivoexpanded autologous bone marrow derived mesenchymal stromalcells in human spinal cord injury/paraplegia. A pilot clinicalstudy.Cytotherapy 2009; 11(7): 897-11.
47. Ding Y, Yan Q, Ruan JW, et al. Electro-acupuncture promotessurvival, differentiation of the bone marrow mesenchymal stemcells as well as functional recovery in the spinal cord-transectedrats. BMC Neurosci 2009; 10: 35.
48. Kuh SU, Cho YE, Yoon DH, Kim KN, Ha Y. Functional recovery after human umbilical cord blood cells transplantation with brain derived neutrophic factor into the spinal cord injured rat. Acta Neurochir2005; 147(9): 985-92.
49. Wang GS, Zhang QZ, Han ZC. Evaluation of neurological functionrecovery following human umbilical cord mesenchymal stem cellstransplantation to injured spinal cord in rats. Chin J Neurosurg2006; 22: 18-21.
50. Doucette JR. The glial cells in the nerve fiber layer of the rat olfactorybulb. Anat Rec 1984; 210(2): 385-91.
51. Ruitenberg MJ, Vukovic J, Sarich J, Busfield SJ, Plant GW. Olfactory ensheathing cells: Characteristics, genetic engineering and therapeutic protocol. J Neurotauma 2006; 23: 468-78.
52. Zhang C, He X, Lan B, Li H. Study on repair of subacute spinal cord injury by transplantation of olfactory ensheathing cells combined with chondroitinase ABC in adult rats. Chin J Repar Reconstruct Surg 2009; 23(1): 8-13.
53. Feron F, Perry C, Cochrane J, et al. Autologous olfactory ensheathingcell transplantation in human spinal cord injury. Brain 2005;128: 2951-60.
54. Tuszynski MH, Grill R, Jones LL, McKay HM, Blesch A. Spontaneous and augmented growth of axons in the primate spinal cord: effects of local injury and nerve growth factor-secreting cell grafts.J Comp Neurol 2002; 449(1): 88-101.
55. Ohta Y, Takenaga M, Tokura Y, et al. Mature adipocyte-derived cells, dedifferentiated fat cells [DFAT], promoted functional recovery from spinal cord injury-induced motor dysfunction in rats. Cell Transplant 2008; 17(8): 877-86.
56. Xu XM, Chen A, Guenard V, Kleitman N, Bunge MB. BridgingSchwann cell transplants promote axonal regeneration from boththe rostral and caudal stumps of transected adult rat spinal cord. JNeurocytology 1997; 26: 1-16.
57. Takami T, Oudega M, Bates ML, Wood PM, Kleitman N, BungeMB. Schwann cell but not olfactory ensheathing glia transplantsimprove hindlimb locomotor performance in the moderately contusedadult rat thoracic spinal cord. J Neurosci 2002; 22: 6670-81.
58. Hurtado A, Moon LD, Maquet V, Blits B, Jerome R, Oudega M.Poly (D,L-lactic acid) macroporous guidance scaffolds seeded with Schwann cells genetically modified to secrete a bi-functional neurotrophin implanted in the completely transected adult rat thoracic spinal cord. Biomaterials 2006; 27: 430-42.
59. Moreno-Manzano V, Rodríguez-Jiménez FJ, García-Roselló M, etal. Activated spinal cord ependymal stem cells rescue neurologicalfunction. Stem Cells 2009; 27(3): 733-43.
60. Vaquero J, Zurita M, Oya S, Santos M. Cell therapy using bonemarrow stromal cells in chronic paraplegic rats: systemic or localadministration? Neurosci Lett 2006; 398: 129-34.
61. Deda H, Inci MC, Kureckci A, et al. Treatment of chronic spinalcord injured patients with Autologous bone marrow-derived haematopoieticstem cell transplantation. Cytotherapy 2008; 6: 551-64.
62. Bakshi A, Barshinger AL, Swanger SA, et al. Lumbar puncturedelivery of bone marrow stromal cells in spinal cord contusion: anovel method for minimally invasive cell transplantation: J Nerotrauma2006; 23: 55-65.
63. Nomura H, Tator CH, Shoichet MS. Bioengineered strategies for spinal cord repair. J Neurotrauma 2006; 23: 496-07.
64. Willerth SM, Arendas KJ, Gittlieb DI, Sakiyama- Elbert SE. Optimization of fibrin scaffolds for differentiation of murine embryonic stem cells into neural lineage cells. Biomaterials 2006; 27: 5990-5903.
65. Tysseling-Mattiace VM, Sahni V, Niece KL, et al. Self-assemblingnanofibers inhibit glial scar formation and promote axon elongationafter spinal cord injury. J Neurosci 2008; 28(14): 3814-23.
66. Tetzlaff W, Okon EB, Karimi-Abdolrezaee S, et al. A systematicreview of cellular transplantation therapies for spinal cord injury. JNeurotrauma 2010; Apr 20 (Epub ahead of print).
67. Kwon BK, Oxland TR, Tetzlaff W. Animal models used in spinalcord regeneration research. Spine 2002; 27(14): 1504-10.
68. Noble LJ, Wrathall JR. Spinal cord contusion in the rat: Morphometric analyses of alterations in the spinal cord. Exp Neurol1985; 88: 135-49.
69. Gruner JA. A monitored contusion model of spinal cord injury in the rat. J Neurotrauma 1992; 9: 123-6.
70. Bresnahan JC, Beattie MS, Todd FD III, Noyes DH. A behavioral and anatomical analysis of spinal cord injury produced by a feedback-controlled impaction device. Exp Neurol 1987; 95: 548-70.
71. Rivlin AS, Tator CH. Effect of duration of acute spinal cord compressionin a new acute cord injury model in the rat. Surg Neurol1978; 10: 38-43.
72. Schaal SM, Kitay BM, Cho KS, et al. Schwann cell transplantationimproves reticulospinal axon growth and forelimb strength aftersevere cervical spinal cord contusion. Cell Transplant 2007; 16:207-28.
73. Guest JD, Hesse D, Schnell L, Schwab ME, Bunge MB, Bunge RP. Influence of IN-1 antibody and acidic FGF-fibrin glue on the response of injured cortico spinal tract axons to human Schwann cell grafts. J Neurosci Res 1997a; 50: 888-05.
74. Guest JD, Rao A, Olson L, Bunge MB, Bunge RP. The ability ofhuman Schwann cell grafts to promote regeneration in the transectednude rat spinal cord. Exp Neurol 1997b; 148: 502-22.
75. Ramon-Cueto A, Cordero MI, Santos-Benito FF, Avila J. Functionalrecovery of paraplegic rats and motor axon regeneration intheir spinal cords by olfactory ensheathing glia. Neuron 2000; 25:425-35.
76. Guest JD, Herrera L, Margitich I, Oliveria M, Marcillo A, Casas CE. Xenografts of expanded primate olfactory ensheathing glia support transient behavioral recovery that is independent of serotonergicor corticospinal axonal regeneration in nude rats followingspinal cord transection. Exp Neurol 2008; 212: 261-74.
77. Parr AM, Kulbatski I, Zahir T, et al. Transplanted adult spinalcord-derived neural stem/progenitor cells promote early functionalrecovery after rat spinal cord injury. Neuroscience 2008; 155: 760-70.
78. Hoffstetter CP, Holmstrom MA, Lilja JA, et al. Allodynia limitsthe usefulness intraspinal neural stem cell grafts: directed differentiationimproves outcome. Nat Neurosci 2005; 8: 346-53.
79. Bottai D, Madaschi L, Di Giulio AM, Gorio A. Viability-dependentpromoting action of adult neural precursors in spinal cord injury.Mol Med 2008; 14: 634-44.
80. Ziv Y, Avidan H, Pluchino S, Martino G, Schwartz M. Synergybetween immune cells and adult neural stem/progenitor cells promotesfunctional recovery from spinal cord injury. Proc Natl AcadSci USA 2006; 103: 13174-79.
81. Pan, HC, Cheng FC, Lai SZ, Yang DY, Wang YC, Lee MS. Enhancedregeneration in spinal cord injury by concomitant treatmentwith granulocyte colony-stimulating factor and neuronal stem cells. J Clin Neurosci 2008; 15: 656-64.
82. Iwanami A, Kaneko S, Nakamura M, et al. Transplantation of human neural stem cells for spinal cord injury in primates. J NeurosciRes 2005; 80: 182-90.
83. Lee SH, Chung YN, Kim YH, et al. Effects of human neural stemcell transplantation in canine spinal cord hemisection. Neurol Res2009; 31(9): 996-1002.
84. Alexanian AR, Crowe MJ, Kurpad SN. Efficient differentiation and integration of lineage-restricted neural precursors in the traumatically injured adult cat spinal cord. J Neurosci Methods 2006; 150:41-46.
85. Cao Q, He Q, Wang Y, et al. Transplantation of ciliary neurotrophicfactor-expressing adult oligodendrocyte precursor cells promotes remyelination and functional recovery after spinalcord injury. J Neurosci 2010; 30(8): 2989-3001.
86. Deng YB, Liu Y, Zhu WB, et al. The co-transplantation of humanbone marrow stromal cells and embryo olfactory ensheathing cells as a new approach to treat spinal cord injury in a rat model. Cytotherapy2008; 10: 551-64.
87. Cizkova D, Rosocha J, Vanicky I, Jergova S, Cizek M. Transplantsof human mesenchymal stem cells improve functional recovery af ter spinal cord injury in the rat. Cell Mol Neurobiol 2006; 26:1167-80.
88. Kamada T, Koda M, Dezawa M, et al. Transplantation of bone marrow stromal cell-derived Schwann cells promotes axonal regeneration and functional recovery after complete transaction of adult rat spinal cord. J Neuropathol Exp Neurol 2005; 64: 37-45.
89. Koda M, Kamada T, Hashimoto M, et al. Adenovirus vectormediatedEx vivo gene transfer of brain-derived neurotrophic factor tobone marrow stromal cells promotes axonal regeneration aftertransplantation in completely transected adult rat spinal cord. EurSpine J 2007; 16: 2206-214.
90. Callera F, do Nascimento RX. Delivery of autologous bone marrowprecursor cells into the spinal cord via lumbar puncture techniquein patients with spinal cord injury: a preliminary safety study. ExpHematol 2006; 34: 130-31.
91. Saito F, Nakatani T, Iwase M, et al. Spinal cord injury treatment with intrathecal autologous bone marrow stromal cell transplantation: the first clinical trial case report. J Trauma 2008; 64: 53-59.
92. Pal R, Gopinath C, Rao NM, et al. Functional recovery after transplantationof bone marrow-derived mesenchymal stromal cells in arat model of spinal cord injury. Cytotherapy 2010; 12(6): 792-806.
93. http://www.medpagetoday.com/PublicHealthPolicy/StemCellResearch/12575.
94. Falci S, Holtz A, Akesson E, et al. Obliteration of a posttraumatic spinal cord cyst with solid human embryonic spinal cord grafts: first clinical attempt. J Neurotrauma 1997; 14: 875-84.
95. Thompson FJ, Reier PJ, Uthman B, et al. Feasibility and safety ofneural tissue transplantation in patients with syringomyelia. J Neurotrauma2001; 18: 931-495.
96. Rabinovitch SS, Seledsov VI. Poveschenko OV, et al. Transplantationtreatment of spinal cord injury patients. Biomed Pharmacother2003; 57(9): 428-433.
97. Engesser-Cesar C, Anderson AJ, Basso DM, Edgerton VR, CotmanCW. Voluntary wheel running improves recovery from a moderate spinal cord injury. J Neurotrauma 2005; 22: 157-71.
98. Pfeifer K, Vroemen M, Blesch A, Weidner N. Adult neural progenitorcells provide a permissive guiding substrate for corticospinalaxon growth following spinal cord injury. Eur J Neurosci 2004;20: 1695-704.
99. Sykova E, Homola A, Mazanec R, et al. Autologous bone marrow transplantation in patients with subacute and chronic spinal cord injury.Cell Transplant 2006; 15(8-9): 675-87.
100. Park HC, Shim YS, Ha H, et al. Treatment of complete spinal cordinjury patients by autologous bone marrow cell transplantation andadministration of granulocyte-macrophage colony stimulating factor.Tissue Eng 2005; 11: 913-22.
101. Xie Z, G Cui, Li B, et al. Curative effect of autologous mesenchymalstem cell transplantation on spinal cord injury. ZhongguoZuzhi Gongcheng Yanjui Linchuang Kangfu Za Zhi 2007; 11:1277-79.
102. Lima C, Pratas-Vital J, Escada P, Hasse-Ferreira A, Capucho C, Peduzzi JD. Olfactory mucosa autografts in human spinal cord injury:a pilot clinical study. J Spinal Cord Med 2006; 29: 191-03.
103. Mackay-Sim A, Feron F, Cochrane J, et al. Autologous olfactoryensheathing cell transplantation in human paraplegia: A 3 yearclinical trial. Brain 2008: 113 (Part 9); 2376-86.
104. Huang H, Chen L, Wang H, et al. Influence of patients' age onfunctional recovery after transplantation of olfactory ensheathingcells into injured spinal cord injury. Chinese Med J 2003; 116:1488-91.
105. Dobkin BH, Curt A, Guest J. Cellular transplants in China: observationalstudy from the largest human experiment in human spinalcord injury. Neurorehabil Neural Repair 2006; 20: 5-13.
106. Tator CH. Review of treatment trials in human spinal cord injury:issues, difficulties and recommendations. Neurosurgery 2006; 59:857-82.
107. Schulz SS. Adult stem cell application in Spinal cord injury. CurrentDrug Targets 2005; 6: 63-73.
108. Rosenfield JV, Gillett GR. Ethics, stem cells and spinal cord repair.Med J Aust 2004; 180: 637-639.
109. Pandya SK. Stem cell transplantation in India: tall claims, questionableethics. Indian J Med Ethics 2008; 5: 15-17.
110. Liu S, Qu Y, Stewart TJ, et al. Embryonic stem cells differentiateinto oligodendrocytes and myelinate in culture and after spinal cordtransplantation. Proc Natl Acad Sci USA 2000; 97(11): 6126-31.
111. Hamada M, Yoshikawa H, Ueda Y, et al. Introduction of theMASH1 gene into mouse embryonic stem cells leads to differentiation of motoneuron precursors lacking Nogo receptor expression that can be applicable for transplantation to spinal cord injury. Neurobiol Dis 2006; 22(3): 509-22.
112. Matsuda R, Yoshikawa M, Kimura H, et al. Cotransplantation of mouse embryonic stem cells and bone marrow stromal cells following spinal cord injury suppresses tumor development. Cell Transplant2009; 18(1): 39-54
113. Faulkner J, Keirstead HS. Human embryonic stem cell-derivedoligodendrocyte progenitors for the treatment of spinal cord injury.Transpl Immunol 2005; 15(2): 131-42.
114. Zhang YW, Denham J, Thies RS. Oligodendrocyte progenitor cellsderived from human embryonic stem cells express neurotrophicfactors. Stem Cells Dev 2006; 15(6): 943-52.
115. Okamura RM, Lebkowski J, Au M, Priest CA, Denham J, Majumdar AS Immunological properties of human embryonic stem cellderivedoligodendrocyte progenitor cells. J Neuroimmunol 2007;192(1-2): 134-44.
116. Yan J, Xu L, Welsh AM, et al. Extensive neuronal differentiationof human neural stem cell grafts in adult rat spinal cord. PLoS Med2007; 4(2): e39.
117. Akesson E, Wolmer-Solberg N, Cederarv M, Falci S, Odeberg J.Human neural stem cells and astrocytes, but not neurons, suppressan allogeneic lymphocyte response. Stem Cell Res 2009; 2(1): 56-67.
118. Tarasenko YI, Gao J, Nie L, et al. Human fetal neural stem cellsgrafted into contusion-injured rat spinal cords improve behavior.Neurosci Res 2007; 85(1): 47-57.
119. Yoo CJ, Yoo YM, Kim YJ. The identification of proteoglycan,collagen and neuron in precursor cells from human fetal spinalcord. Neurosci Lett 2009; 457(3):151-4.
120. Ao Q, Wang AJ, Chen GQ, Wang SJ, Zuo HC, Zhang XF. Combined transplantation of neural stem cells and olfactory ensheathing cells for the repair of spinal cord injuries. Med Hypotheses 2007;69(6): 1234-7.
121. Ronsyn MW, Daans J, Spaepen G, et al. Plasmid-based genetic modification of human bone marrow-derived stromal cells: analysis of cell survival and transgene expression after transplantation in ratspinal cord. BMC Biotechnol 2007; 7: 90.
122. Parr AM, Kulbatski I, Wang XH, Keating A, Tator CH. Fate of transplanted adult neural stem/progenitor cells and bone marrow derived mesenchymal stromal cells in the injured adult rat spinalcord and impact on functional recovery. Surg Neurol 2008; 70(6):600-7.
123. Cho SR, Yang MS, Yim SH, et al. Neurally induced umbilical cordblood cells modestly repair injured spinal cords. Neuroreport 2008;19(3): 1259-63.
124. Ban DX, Kong XH, Feng SQ, Ning GZ, Chen JT, Guo SF. Intraspinalcord graft of autologous activated Schwann cells efficientlypromotes axonal regeneration and functional recovery afterrat's spinal cord injury. Brain Res 2009; 1256: 149-61.
125. Zhang L, Zhang HT, Hong SQ, Ma X, Jiang XD, Xu RX.Cografted Wharton's Jelly Cells-derived Neurospheres and BDNFPromote Functional Recovery After Rat Spinal Cord Transection.Neurochem Res 2009; 34(11): 2030-39.